本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Castle Biosciences, Inc.

39.44
-0.1600-0.40%
盤後38.66-0.7800-1.98%19:34 EST
成交量:36.16萬
成交額:1,425.76萬
市值:11.51億
市盈率:-90.84
高:39.87
開:39.46
低:39.15
收:39.60
52周最高:40.61
52周最低:14.59
股本:2,918.87萬
流通股本:2,672.49萬
量比:1.02
換手率:1.35%
股息:- -
股息率:- -
每股收益(TTM):-0.4342
每股收益(LYR):0.6569
淨資產收益率:-2.69%
總資產收益率:-1.72%
市淨率:2.46
市盈率(LYR):60.04

資料載入中...

2020/04/15

重要事件披露

Current report, items 7.01, 8.01, and 9.01
2020/04/01

重要事件披露

Current report, items 5.02, 7.01, and 8.01
2020/03/10

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/03/10

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/10

重要事件披露

Current report, items 2.02, 7.01, and 9.01
2020/03/05

重要事件披露

Current report, items 1.01 and 2.04
2020/02/12

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/11

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/05

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/09

重要事件披露

Current report, items 2.02, 7.01, and 9.01
2019/12/19

重要事件披露

Current report, items 1.01, 5.02, and 9.01
2019/11/14

重要事件披露

Current report, items 2.02, 7.01, and 9.01
2019/11/12

重要事件披露

Current report, items 2.02 and 9.01
2019/11/12

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/09/03

重要事件披露

Current report, items 2.02 and 9.01
2019/09/03

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/08/05

超過5%披露

General statement of acquisition of beneficial ownership
2019/07/31

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/31

持股變動聲明

Statement of changes in beneficial ownership of securities